These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1823814)

  • 1. Updating the procedure for metaiodobenzylguanidine labelling with iodine radioisotopes employed in industrial production.
    Franceschini R; Mosca R; Bonino C
    J Nucl Biol Med (1991); 1991; 35(4):183-5. PubMed ID: 1823814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity.
    Donovan AC; Valliant JF
    Nucl Med Biol; 2008 Oct; 35(7):741-6. PubMed ID: 18848658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast high-yield labelling and quality control of [123I]- and [131I]MIBG.
    Verbruggen RF
    Int J Rad Appl Instrum A; 1987; 38(4):303-4. PubMed ID: 3040631
    [No Abstract]   [Full Text] [Related]  

  • 5. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
    Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
    J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of radioiodination of meta-iodobenzylguanidine (MIBG) catalysed by in situ generated Cu(I) and directly added Cu(II).
    Prabhakar G; Mehra KS; Ramamoorthy N; Chattopadhyay S; Oommen R; Narasimhan S; Nair NA; Gunasekaran S
    Appl Radiat Isot; 1999 Jun; 50(6):1011-4. PubMed ID: 10355103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
    Vaidyanathan G; Zalutsky MR
    Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine production and quality control of 123I-labelled mIBG at NAC.
    Rossouw DD
    Int J Rad Appl Instrum A; 1992 Oct; 43(10):1301-2. PubMed ID: 1330981
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
    Bruchelt G; Girgert R; Buck J; Wolburg H; Niethammer D; Treuner J
    Cancer Res; 1988 Jun; 48(11):2993-7. PubMed ID: 3365688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of specific activity on cardiac uptake of iodine-123-MIBG.
    Farahati J; Bier D; Scheubeck M; Lassmann M; Schelper LF; Grelle I; Hanscheid H; Biko J; Graefe KH; Reiners C
    J Nucl Med; 1997 Mar; 38(3):447-51. PubMed ID: 9074536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
    Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
    Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a kit-form analog of metaiodobenzylguanidine.
    Lee H; Inbasekaran MN; Wieland DM; Sherman PS; Fisher SJ; Mangner TJ; Rogers WL; Clinthorne NH
    J Nucl Med; 1986 Feb; 27(2):256-67. PubMed ID: 3712043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
    Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
    J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.
    Smets LA; Rutgers M
    J Nucl Biol Med (1991); 1991; 35(4):191-4. PubMed ID: 1823816
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
    Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient production of therapeutic doses of [131I]-metaiodobenzylguanidine for clinical use.
    Prabhakar G; Mathur A; Shunmugam G; Teje YD; Sachdev SS; Sivaprasad N
    Appl Radiat Isot; 2011 Jan; 69(1):63-7. PubMed ID: 20933432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
    Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficient batch preparation of high specific activity.
    Amartey JK; Al-Jammaz I; Lambrecht RM
    Appl Radiat Isot; 2001 May; 54(5):711-4. PubMed ID: 11258518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, radiolabelling and stability of radioiodinated m-iodobenzylguanidine, a review.
    Wafelman AR; Konings MC; Hoefnagel CA; Maes RA; Beijnen JH
    Appl Radiat Isot; 1994 Oct; 45(10):997-107. PubMed ID: 7994289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.